Log in to your Inderes Free account to see all free content on this page.
Bavarian Nordic
177.65 DKK
-2.98 %
Less than 1K followers
BAVA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Bavarian Nordic
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 135.63 | 187.00 | 268.80 | 213.40 | 177.45 | 189.35 | 190.85 |
| Shares | 39.7 | 54.4 | 58.3 | 70.7 | 78.1 | 78.9 | 78.3 |
| Market cap | 5,387.5 | 10,175.6 | 15,671.0 | 15,094.9 | 13,858.4 | 14,931.2 | 14,937.8 |
| Enterprise value | 6,747.1 | 8,976.1 | 12,926.5 | 13,442.7 | 12,136.2 | 12,884.4 | - |
| EV/S | 10.2 | 4.8 | 6.8 | 4.3 | 1.7 | 2.3 | - |
| EV/EBITDA | neg. | 12.1 | 172.9 | 40.9 | 4.6 | 8.0 | - |
| EV/EBIT | neg. | 23.6 | neg. | neg. | 8.1 | 13.7 | - |
| P/E | neg. | 36.7 | neg. | neg. | 9.2 | 15.0 | 10.8 |
| P/B | 2.89 | 2.08 | 2.13 | 2.11 | 1.34 | 1.31 | 1.16 |
| P/S | 8.1 | 5.5 | 8.3 | 4.8 | 2.0 | 2.6 | 2.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 26.5 % | 55.9 % | 61.0 % | 57.7 % | 72.0 % | 79.2 % | 86.1 % |
| Gearing ratio | 98.2 % | 9.6 % | 13.2 % | 16.7 % | 1.4 % | 1.1 % | 1.0 % |
Login required
This content is only available for logged in users